THO-RPE
DEAD

Serial Number

98278309

Owner

Sentinel BioTherapeutics Inc.

Attorney

Nathan T. Harris

Filing Date

Nov 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

THO-RPE Trademark

Serial Number: 98278309

THO-RPE is a trademark filed by Sentinel BioTherapeutics Inc. on November 20, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Sentinel BioTherapeutics Inc. (4 trademarks)

1 Jefferson Court
Newtown, PA 18940

Entity Type: 03

Trademark Details

Filing Date

November 20, 2023

Registration Date

Not Registered

Published for Opposition

August 6, 2024

Goods & Services

pharmaceutical preparations comprising cells for application in the thoracic or pleural cavities for the treatment of disease

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 4, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 4, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 2, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jul 2, 2025 EX2G
SOU EXTENSION 2 FILED
Jul 1, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 2, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 2, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 1, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 1, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2024 NWOS